2020
DOI: 10.1111/trf.15945
|View full text |Cite
|
Sign up to set email alerts
|

Targeted exome sequencing designed for blood group, platelet, and neutrophil antigen investigations: Proof‐of‐principle study for a customized single‐test system

Abstract: Background Immunohematology reference laboratories provide red blood cell (RBC), platelet (PLT), and neutrophil typing to resolve complex cases, using serology and commercial DNA tests that define clinically important antigens. Broad‐range exome sequencing panels that include blood group targets provide accurate blood group antigen predictions beyond those defined by serology and commercial typing systems and identify rare and novel variants. The aim of this study was to design and assess a panel for targeted … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
30
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2

Relationship

1
5

Authors

Journals

citations
Cited by 16 publications
(30 citation statements)
references
References 59 publications
(94 reference statements)
0
30
0
Order By: Relevance
“…245 targeted blood group exome sequencing samples with serological phenotypes for ABO, D, C, c, E, e, K and k blood groups(30). This dataset was important to validate the accuracy of the algorithm with established methods currently used to determine ABO, D, C, c, E, e, K, k phenotypes.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…245 targeted blood group exome sequencing samples with serological phenotypes for ABO, D, C, c, E, e, K and k blood groups(30). This dataset was important to validate the accuracy of the algorithm with established methods currently used to determine ABO, D, C, c, E, e, K, k phenotypes.…”
Section: Methodsmentioning
confidence: 99%
“…Proof of Principle Algorithm Development dataset: Initial development was undertaken using 13 in-house targeted exome sequencing (TES) samples for which serological data for 14 blood groups (+ 4 samples with SNParray) were available with the remaining 22 blood groups were predicted (27), provided in the supplementary table 3. In addition 45 previously published complex blood group serology cases with TES, from the Australian Red Cross Lifeblood Red Cell Reference Laboratory with manually predicted blood groups (Supplementary Table 4) (17,27,30) were analysed.…”
Section: Datasetsmentioning
confidence: 99%
See 1 more Smart Citation
“…(Supplementary Table 4). 17,18,30 South East Queensland Indigenous TES data: This dataset comprised 244 targeted blood group exome sequencing samples with serologically validated phenotypes for ABO, D, C, c, E, e, K and k blood groups. 3 MedSeq project: 110 whole-genome sequencing samples (30X) from the MedSeq Project randomized controlled trial (accession number phs000958) were accessed through dbGaP authorized access.…”
Section: Datasetsmentioning
confidence: 99%
“…[20][21][22][23][24] NGS approaches including targeted exome sequencing (TES), whole exome sequencing (WES), and whole genome sequencing (WGS) have the potential to provide a new basis of pre-transfusion testing by facilitating the accurate characterization of an individual's complete blood group profile, supporting precision-based medicine. 25,26 Curated and detailed DNA-phenotype-annotated databases storing blood group allele and antigen data has been developed by ISBT, providing tools for blood type calling from genetic data. As NGS is increasingly employed in immunohematology, Erythrogene, a customdesigned blood group allele database associated with the 1000 Genomes (1KGP3) project has been developed and applied.…”
Section: Introductionmentioning
confidence: 99%